AC Immune (ACIU) Leases (2016 - 2025)

AC Immune (ACIU) has 9 years of Leases data on file, last reported at $5.7 million in Q4 2025.

• Quarterly Leases fell 8.48% year-over-year to $5.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.7 million (down 8.48% YoY) and the FY2025 annual result came in at $5.5 million, down 11.77% from the prior year.
• Leases declined to $5.7 million in Q4 2025 per ACIU's latest filing, from $5.8 million in the prior quarter.
• Across five years, Leases topped out at $4.0 billion in Q4 2023 and bottomed at $2.6 million in Q3 2022.
• The 5-year median for Leases is $4.8 million (2025), against an average of $765.5 million.
• The widest annual swing landed in 2021, when Leases jumped 139704.44%; it then sank 99.91% in 2022.
• Tracing ACIU's Leases over 5 years: stood at $3.2 billion in 2021, then slumped by 99.91% to $2.9 million in 2022, then soared by 135580.19% to $4.0 billion in 2023, then sank by 99.84% to $6.2 million in 2024, then fell by 8.48% to $5.7 million in 2025.
• Per Business Quant, the three latest ACIU Leases figures stand at $5.7 million (Q4 2025), $5.8 million (Q3 2025), and $6.0 million (Q2 2025).

Peer Comparison